Clinical study will use advanced MRI on breast cancer patients

Jodelle Maglaya | | Health Imaging | Cardiac Imaging

A two-year clinical study is underway in which advanced imaging methods will be tested, with the hopes of providing valuable information, support and treatment to breast cancer patients and their physicians. The team will use MRI and analysis to make early predictions on how a specific patient’s tumor will eventually respond to therapy.

The clinical study is the first of its kind to focus primarily on cancer, and will be done through partnerships with Seton Healthcare Family, Texas Oncology and Austin Radiological Association and the University of Texas at Austin. The study is funded by the National Institutes of Health’s National Cancer Institute and the Cancer Prevention and Research Institute of Texas.

The study began Oct. 1 and the team plans to enroll 100 breast cancer patients from Seton and Texas Oncology. 

Read the full article below:

New Clinical Partnership Uses Advanced Imaging Methods to Fight Breast Cancer

Jodelle Maglaya

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Related Content

Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
FDA clears AI screening tool for cardiac amyloidosis
Global shortage of nuclear imaging isotopes may be over
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
FDA clears AI tool that flags signs of heart disease in chest CT scans
AI-enabled plaque assessments help cardiologists ID high-risk CAD patients

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.